Overview
Announcements

Ordinary Rebalance | Solactive Transatlantic Healthcare Equity Index | Effective Date 9th October 2023

In the ordinary rebalance, the following composition will be implemented effective open 09.10.2023:

ABBOTT LABORATORIES
ABBVIE INC
AGILENT TECHNOLOGIES INC
ALCON INC
AMGEN INC
BAYER AG
BECTON DICKINSON AND CO
BIOGEN INC
BRISTOL-MYERS SQUIBB CO
COLOPLAST AS CLASS B
CONVATEC GROUP PLC
COOPER COMPANIES INC
DANAHER CORP
DENTSPLY SIRONA INC
ENCOMPASS HEALTH CORP
ENSIGN GROUP INC
ESSILORLUXOTTICA
EXELIXIS INC
GILEAD SCIENCES INC
GSK PLC
HOLOGIC INC
INCYTE CORP
IQVIA HOLDINGS INC
JAZZ PHARMACEUTICALS PLC
JOHNSON & JOHNSON
LABORATORY CRP OF AMER HLDGS
MEDTRONIC PLC
MERCK & CO. INC.
NEUROCRINE BIOSCIENCES INC
NOVARTIS AG
PFIZER INC
PRESTIGE CONSUMER HEALTHCARE INC
QIAGEN NV
QUEST DIAGNOSTICS INC
REGENERON PHARMACEUTICALS
REVVITY INC
ROCHE HOLDING AG
ROYALTY PHARMA PLC- CL A
SANOFI SA
SEAGEN INC
SIEMENS HEALTHINEERS AG
STERIS PLC
STRYKER CORP
THERMO FISHER SCIENTIFIC INC
UCB SA
UNITED THERAPEUTICS CORP
UNITEDHEALTH GROUP INC
VERALTO CORP
VERTEX PHARMACEUTICALS INC
WEST PHARMACEUTICAL SERVICES INC
ZIMMER BIOMET HOLDINGS INC